Leukocyte interleukin injection (LI) immunotherapy extends overall survival (OS) in treatment-naive low-risk (LR) locally advanced primary squamous cell carcinoma of the head and neck: The IT-MATTERS study.

Eyal Talor, Dusan Markovic,Philip T. Lavin, John Cipriano,Jozsef Timar,Andrey Karpenko,Igor Bondarenko,Srboljub Stosic, Hrvoje Sobat,Jayamini Horadugoda, Aliaksandr Zhukavets,Rajnish Vasant Nagarkar, Nazim Imamovic,Chih-Yen Chien, Magdalena Bankowska-Wozniak, Mihaly Kisely,Raphael Feinmesser, James Edward Young, Christopher L. Oliver,Sheng-Po Hao

JOURNAL OF CLINICAL ONCOLOGY（2022）

引用 0|浏览31

暂无评分

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要